MARKET

IMMX

IMMX

Immix Biopharma Inc
NASDAQ
4.840
+0.690
+16.63%
Closed 19:57 12/04 EST
OPEN
4.140
PREV CLOSE
4.150
HIGH
5.08
LOW
4.070
VOLUME
1.23M
TURNOVER
0
52 WEEK HIGH
5.08
52 WEEK LOW
1.340
MARKET CAP
162.52M
P/E (TTM)
-6.2516
1D
5D
1M
3M
1Y
5Y
1D
Immix Biopharma Unveils Breakthrough Approach for Relapsed AL Amyloidosis in New Presentation
Reuters · 2d ago
Immix Biopharma Unveils Breakthrough Strategy for Relapsed/Refractory AL Amyloidosis
Reuters · 2d ago
Weekly Report: what happened at IMMX last week (1124-1128)?
Weekly Report · 4d ago
Immix Biopharma Updates Accounting Firm Consents
TipRanks · 11/26 22:28
Weekly Report: what happened at IMMX last week (1117-1121)?
Weekly Report · 11/24 10:39
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 11/21 21:05
Weekly Report: what happened at IMMX last week (1110-1114)?
Weekly Report · 11/17 10:40
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 11/12 21:05
More
About IMMX
Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the application of chimeric antigen receptor cell therapy (CAR- T) in light chain (AL) Amyloidosis and select immune-mediated diseases. The Company's lead cell therapy candidate CAR-T NXC-201 (NXC-201), which is being evaluated in its ongoing United States Phase Ib/II NEXICART-2 (NCT06097832) clinical trial. Its lead program, NXC-201 is a next generation CAR-T targeting B-cell maturation antigen. CAR-T cell therapy is a type of immunotherapy that uses the patient’s own immune cells, modified with its proprietary technology. Its N-GENIUS cell engineering platform with EXPAND technology has produced clinical-stage CAR-T NXC-201, targeting B cell maturation antigen, which is autologous CAR-T being developed to treat AL Amyloidosis.

Webull offers Immix Biopharma Inc stock information, including NASDAQ: IMMX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMMX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMMX stock methods without spending real money on the virtual paper trading platform.